ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease causing irreversible lung scarring and loss of pulmonary function. IPF Patients suffer from a high rate of pulmonary infections and acute exacerbations of disease that further contribute to pulmonary decline. Low expression of the ind...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mucosal Immunol
Egile Nagusiak: Hrusch, Cara L., Manns, Stephenie T., Bryazka, Dana, Casaos, Joshua, Bonham, Catherine A., Jaffery, Mohammad R., Blaine, Kelly M., Mills, Kathleen A.M., Verhoef, Philip A., Adegunsoye, Ayodeji O., Williams, Jesse W., Tjota, Melissa Y., Moore, Tamson V., Strek, Mary E., Noth, Imre, Sperling, Anne I.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5681437/
https://ncbi.nlm.nih.gov/pubmed/28488693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mi.2017.42
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak